Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal ErbB4 / HER4 antibody. Suitable for I-ELISA, WB, IHC-P and reacts with Recombinant fragment - Human, Mouse, Human samples. Cited in 5 publications.
View Alternative Names
HER4, ERBB4, Receptor tyrosine-protein kinase erbB-4, Proto-oncogene-like protein c-ErbB-4, Tyrosine kinase-type cell surface receptor HER4, p180erbB4
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (AB219208)
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling ErbB4 / HER4 with ab219208 at 1/1000 dilution followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP Polymer). Positive staining on the human breast carcinoma (PMID : 19239686) is observed. The section was incubated with ab219208 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP Polymer).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- I-ELISA
Lab
Indirect ELISA - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (AB219208)
Indirect ELISA analysis of Human ERBB2 Recombinant Protein and Human ERBB4 Recombinant Protein at varying antigen concentrations of 500-0 ng/ml using ab219208 at 1000 ng/mL and secondary antibody Goat Anti-Rabbit IgG H&L (HRP) at 1/50000 dilution. Substrate solution was 3,3’,5,5’-Tetramethylbenzidine (TMB).
- I-ELISA
Lab
Indirect ELISA - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (AB219208)
ELISA analysis of Human ERBB4 recombinant protein at 1000 ng/mL with ab219208. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (AB219208)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The molecular weight observed is consistent with what has been described in the literature (PMID : 22761786) Lane 4 was developed using a higher sensitivity ECL substrate.
Exposure time : Lane 1 : 70 seconds; Lanes 2-3 : 48 seconds; Lane 4 : 3 minutes.
All lanes:
Western blot - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (ab219208) at 1/1000 dilution
Lane 1:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
4T1 (mouse mammary gland carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 180 kDa
false
- WB
Lab
Western blot - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (AB219208)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] (ab219208) at 1/1000 dilution
Lane 1:
His-tagged Recombinant Human ErbB2 protein (aa676-1255)
Lane 2:
His-tagged Recombinant Human ErbB4 protein (aa676-1308)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 90 kDa,81 kDa
false
Exposure time: 180s
Related conjugates and formulations (3)
-
Anti-ErbB4 / HER4+ErbB2 / HER2 antibody [EPR22665-104] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ErbB2 / HER2 + ErB4 / HER4 antibody [EPR22665-104]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-ErbB2 / HER2 + ErbB4 / HER4 antibody [EPR22665-104]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ErbB2 and ErbB4 serve significant roles in cellular processes such as cell growth differentiation and survival. ErbB2 typically forms heterodimers with other ErbB family members as it does not have an identified ligand. ErbB4 can function in both homo- and heterodimers. These complexes transmit signals inside the cell to influence transcription and other cellular responses. Their involvement is important for normal development and maintenance of various tissues.
Pathways
ErbB2 and ErbB4 participate in the PI3K/Akt and MAPK signaling pathways which are essential for mediating cellular responses like proliferation and survival. In these pathways they are closely related to proteins such as PI3K and Akt which are vital for transmitting and amplifying the signals initiated by ErbB receptor activation. These pathways ensure appropriate cellular responses to external stimuli and maintain cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
International journal of endocrinology 2024:1672096 PubMed39734383
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pulmonary circulation 14:e12439 PubMed39411231
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:530 PubMed39290955
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of dairy science 105:5238-5260 PubMed35346464
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 14:154 PubMed34774079
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com